1
Dinnessen, Manette A.W., van der Poel, Marjolein W.M., Tonino, Sanne H., Visser, Otto, Blijlevens, Nicole M.A., de Jong, Daphne, Lam, King H., Kersten, Marie José, Lugtenburg, Pieternella J., Dinmohamed, Avinash G.
Veröffentlicht in: Dinnessen , M A W , van der Poel , M W M , Tonino , S H , Visser , O , Blijlevens , N M A , de Jong , D , Lam , K H , Kersten , M J , Lugtenburg , P J & Dinmohamed , A G 2021 , ' Stage-specific trends in primary therapy and survival in follicular lymphoma : a nationwide population-based analysis in the Netherlands, 1989–2016 ' , Leukemia , vol. 35 , no. 6 , pp. 1683-1695 . https://doi.org/10.1038/s41375-020-01048-6;
2021
Veröffentlicht in: Dinnessen , M A W , van der Poel , M W M , Tonino , S H , Visser , O , Blijlevens , N M A , de Jong , D , Lam , K H , Kersten , M J , Lugtenburg , P J & Dinmohamed , A G 2021 , ' Stage-specific trends in primary therapy and survival in follicular lymphoma : a nationwide population-based analysis in the Netherlands, 1989–2016 ' , Leukemia , vol. 35 , no. 6 , pp. 1683-1695 . https://doi.org/10.1038/s41375-020-01048-6;
2021
2
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
3
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S.P., Zijlstra, Josée M., Chamuleau, Martine E.D., Kersten, Marie José, Plattel, Wouter J., Durmaz, Mujde, Lugtenburg, Elly, Stevens, Wendy B.C., Mous, Rogier, de Vries, Elisabeth G.E., van der Poel, Marjolein W.M., Nannan Panday, Prashant V., Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M E D , Kersten , M J , Plattel , W J , Durmaz , M , Lugtenburg , E , Stevens , W B C , Mous , R , de Vries , E G E , van der Poel , M W M , Nannan Panday , P V , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2985-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M E D , Kersten , M J , Plattel , W J , Durmaz , M , Lugtenburg , E , Stevens , W B C , Mous , R , de Vries , E G E , van der Poel , M W M , Nannan Panday , P V , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood advances , vol. 5 , no. 15 , pp. 2985-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
4
Meeuwes, Frederik O, Brink, Mirian, Plattel, Wouter, Van der Poel, Marjolein W M, Kersten, Marie José, Wondergem, Mariëlle, Böhmer, Lara, Woei-A-Jin, F J Sherida H, Visser, Otto, Oostvogels, Rimke, Jansen, Patty M, Neelis, Karen J, Crijns, Anne P G, Daniëls, Laurien A, Snijders, Tjeerd J F, Vermaat, Joost S P, Huls, Gerwin A, Nijland, Marcel
Veröffentlicht in: Meeuwes , F O , Brink , M , Plattel , W , Van der Poel , M W M , Kersten , M J , Wondergem , M , Böhmer , L , Woei-A-Jin , F J S H , Visser , O , Oostvogels , R , Jansen , P M , Neelis , K J , Crijns , A P G , Daniëls , L A , Snijders , T J F , Vermaat , J S P , Huls , G A & Nijland , M 2024 , ' Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands ' , Haematologica , vol. 109 , no. 4 , pp. 1163-1170 . https://doi.org/10.3324/haematol.2023.283174;
2024
Veröffentlicht in: Meeuwes , F O , Brink , M , Plattel , W , Van der Poel , M W M , Kersten , M J , Wondergem , M , Böhmer , L , Woei-A-Jin , F J S H , Visser , O , Oostvogels , R , Jansen , P M , Neelis , K J , Crijns , A P G , Daniëls , L A , Snijders , T J F , Vermaat , J S P , Huls , G A & Nijland , M 2024 , ' Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands ' , Haematologica , vol. 109 , no. 4 , pp. 1163-1170 . https://doi.org/10.3324/haematol.2023.283174;
2024
5
Spanjaart, Anne M., Pennings, Elise R.A., Mutsaers, Pim G.N.J., van Dorp, Suzanne, Jak, Margot, van Doesum, Jaap A., de Boer, Janneke W., Niezink, Anne G.H., Kos, Milan, Vermaat, Joost S.P., Sijs-Szabo, Aniko, van der Poel, Marjolein W.M., Nijhof, Inger S., Kuipers, Maria T., Chamuleau, Martine E.D., Lugtenburg, Pieternella J., Doorduijn, Jeanette K., Serroukh, Yasmina I.M., Minnema, Monique C., van Meerten, Tom, Kersten, Marie José
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023
Veröffentlicht in: Spanjaart , A M , on behalf of the Dutch CAR-T Tumorboard Consortium , Pennings , E R A , Mutsaers , P G N J , van Dorp , S , Jak , M , van Doesum , J A , de Boer , J W , Niezink , A G H , Kos , M , Vermaat , J S P , Sijs-Szabo , A , van der Poel , M W M , Nijhof , I S , Kuipers , M T , Chamuleau , M E D , Lugtenburg , P J , Doorduijn , J K , Serroukh , Y I M , Minnema , M C , van Meerten , T & Kersten , M J 2023 , ' The Dutch CAR-T Tumorboard Experience : Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands ' , Cancers , vol. 15 , no. 17 , 4334 . https://doi.org/10.3390/cancers15174334;
2023